Asclepix Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Asclepix Therapeutics

Access the complete profile.

Asclepix Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	301 W 29th St Ste 2004 Baltimore, MD 21211

Note: Revenues for privately held companies are statistical evaluations.


Asclepix Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Asclepix Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Asclepix Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Asclepix Therapeutics Annual Revenue and Growth Rate

Asclepix Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Asclepix Therapeutics's revenues are gauged from an analysis of company filings.

Asclepix Therapeutics's Income Statement (based on Industry Averages)

Asclepix Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Asclepix Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 26, 2024	9	80%	$13 MM
Complete list of funding rounds and total amounts in the Company Report

Market Share of Asclepix Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Asclepix Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Asclepix Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PGDX	Baltimore, MD	100
LIEBER INSTITUTE	Baltimore, MD	34
PERSONAL GENOME DIAGNOSTICS	Baltimore, MD	30
MARITIME APPLIED PHYSICS	Curtis Bay, MD	16
FRIENDS RESEARCH INSTITUTE	Baltimore, MD	15
RCT SYSTEMS	Baltimore, MD	14

Future Competition: Asclepix Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Asclepix Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)